Cumbo Alexander
Insider CIK 1685994 · RARX Director · STOK Director · SLDB President and CEO, Director · CLYM Director · VOR Director · VERV Director · SRPT VP, Head of Commercial
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2026-09-23 | 2026-09-25 | 39,674 | — | $0 | 39,674 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2026-09-23 | 2026-09-25 | 39,674 | — | $0 | 39,674 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 56,345 | — | $0 | 56,345 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2026-06-05 | 2026-06-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | S Sale | 2026-02-18 | 2026-02-18 | 16,644 | $5.82 | $96.9K | 235,405 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2026-02-13 | 2026-02-18 | 30,031 | — | $0 | 60,063 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2026-02-13 | 2026-02-18 | 30,031 | — | $0 | 252,049 | SEC↗ |
| SLDB Solid Biosciences Inc. | S Sale | 2026-02-04 | 2026-02-06 | 48,913 | $6.44 | $315.0K | 222,018 | SEC↗ |
| SLDB Solid Biosciences Inc. | S Sale | 2026-02-02 | 2026-02-02 | 80,258 | $6.44 | $516.9K | 270,931 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2026-01-31 | 2026-02-02 | 100,400 | — | $0 | 301,200 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2026-01-31 | 2026-02-02 | 100,400 | — | $0 | 351,189 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2026-01-29 | 2026-04-21 | 169,401 | — | $0 | 169,401 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2026-01-29 | 2026-02-02 | 169,401 | — | $0 | 0 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2026-01-29 | 2026-02-02 | 254,900 | — | $0 | 254,900 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2026-01-29 | 2026-02-02 | 509,850 | — | $0 | 509,850 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2026-01-29 | 2026-02-02 | 169,401 | — | $0 | 250,789 | SEC↗ |
| SLDB Solid Biosciences Inc. | S Sale | 2025-12-03 | 2025-12-04 | 10,808 | $5.11 | $55.2K | 81,388 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2025-12-02 | 2025-12-04 | 28,612 | — | $0 | 28,613 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2025-12-02 | 2025-12-04 | 28,612 | — | $0 | 92,196 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2025-08-14 | 2025-08-18 | 168,750 | — | $0 | 168,750 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2025-08-14 | 2025-08-18 | 337,500 | — | $0 | 337,500 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 42,200 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 136,139 | — | $0 | 0 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2025-07-16 | 2025-07-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 42,200 | — | $0 | 42,200 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2025-06-04 | 2025-06-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2025-03-28 | 2025-04-01 | 80,000 | — | $0 | 80,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | S Sale | 2025-02-14 | 2025-02-18 | 11,365 | $3.96 | $45.0K | 60,717 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2025-02-13 | 2025-02-18 | 30,031 | — | $0 | 90,094 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2025-02-13 | 2025-02-18 | 30,031 | — | $0 | 72,082 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2025-01-31 | 2025-02-11 | 401,600 | — | $0 | 401,600 | SEC↗ |
| SLDB Solid Biosciences Inc. | S Sale | 2024-12-03 | 2024-12-04 | 11,114 | $5.60 | $62.2K | 38,484 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2024-12-02 | 2024-12-04 | 28,612 | — | $0 | 57,225 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2024-12-02 | 2024-12-04 | 28,612 | — | $0 | 49,598 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2024-06-26 | 2024-06-28 | 136,139 | — | $0 | 136,139 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2024-02-13 | 2024-02-16 | 240,250 | — | $0 | 240,250 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2024-02-13 | 2024-02-16 | 120,125 | — | $0 | 120,125 | SEC↗ |
| SLDB Solid Biosciences Inc. | S Sale | 2023-12-04 | 2023-12-05 | 11,757 | $2.77 | $32.6K | 17,439 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise deriv | 2023-12-02 | 2023-12-05 | 28,612 | — | $0 | 85,837 | SEC↗ |
| SLDB Solid Biosciences Inc. | M Exercise | 2023-12-02 | 2023-12-05 | 28,612 | — | $0 | 29,196 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 26,642 | — | $0 | 26,642 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2022-12-02 | 2022-12-05 | 114,449 | — | $0 | 114,449 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2022-12-02 | 2022-12-05 | 228,900 | — | $0 | 228,900 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award | 2022-12-02 | 2022-12-05 | 584 | — | $0 | 584 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-13 | 31,000 | — | $0 | 31,000 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 25,000 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 15,000 | — | $0 | 0 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2020-02-28 | 2020-02-28 | 37,500 | — | $0 | 37,500 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2020-02-28 | 2020-02-28 | 6,700 | — | $0 | 8,567 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2019-12-13 | 2019-12-17 | 2,727 | — | $0 | 1,123 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2019-12-13 | 2019-12-17 | 3,895 | — | $0 | 0 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2019-12-13 | 2019-12-17 | 26,084 | — | $0 | 20,881 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2019-12-13 | 2019-12-17 | 26,084 | $26.24 | $684.4K | 43,867 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2019-12-13 | 2019-12-17 | 32,706 | $125.50 | $4.10M | 11,161 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2019-12-13 | 2019-12-17 | 9,294 | $125.50 | $1.17M | 1,867 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2019-12-13 | 2019-12-17 | 3,895 | $13.71 | $53.4K | 17,783 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2019-12-13 | 2019-12-17 | 2,727 | $13.71 | $37.4K | 13,888 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2019-06-11 | 2019-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2019-03-28 | 2019-03-29 | 4,876 | — | $0 | 13,326 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2019-03-28 | 2019-03-29 | 2,165 | $118.68 | $256.9K | 11,161 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2019-03-04 | 2019-03-04 | 45,000 | — | $0 | 45,000 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | D To issuer | 2019-02-28 | 2019-03-04 | 3,375 | — | $0 | 8,450 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2019-02-01 | 2019-02-01 | 2,250 | — | $0 | 0 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2019-02-01 | 2019-02-01 | 5,250 | — | $0 | 46,965 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2019-02-01 | 2019-02-01 | 2,250 | $13.90 | $31.3K | 25,016 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2019-02-01 | 2019-02-01 | 5,250 | $26.24 | $137.8K | 30,266 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2019-02-01 | 2019-02-01 | 15,000 | $140.00 | $2.10M | 15,266 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2018-11-14 | 2018-11-15 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2018-08-08 | 2018-08-08 | 6,000 | $121.02 | $726.1K | 22,766 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2018-07-09 | 2018-07-11 | 11,914 | $13.90 | $165.6K | 2,250 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2018-07-09 | 2018-07-11 | 11,924 | $13.71 | $163.5K | 3,850 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2018-07-09 | 2018-07-11 | 9,944 | $13.71 | $136.3K | 3,895 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2018-07-09 | 2018-07-11 | 11,924 | $13.71 | $163.5K | 40,690 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2018-07-09 | 2018-07-11 | 11,914 | $137.32 | $1.64M | 28,766 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2018-07-09 | 2018-07-11 | 11,914 | $13.90 | $165.6K | 40,680 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2018-07-09 | 2018-07-11 | 9,944 | $137.32 | $1.37M | 28,766 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2018-07-09 | 2018-07-11 | 9,944 | $13.71 | $136.3K | 38,710 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2018-07-09 | 2018-07-11 | 11,924 | $137.32 | $1.64M | 28,766 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2018-05-22 | 2018-05-24 | 4,876 | — | $0 | 0 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2018-05-22 | 2018-05-24 | 1,435 | $89.22 | $128.0K | 28,766 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2018-05-22 | 2018-05-24 | 4,876 | — | $0 | 30,201 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2018-03-15 | 2018-03-16 | 241 | — | $0 | 1,485 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2018-03-15 | 2018-03-16 | 835 | — | $0 | 5,001 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2018-03-15 | 2018-03-16 | 1,370 | — | $0 | 11,415 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2018-03-15 | 2018-03-16 | 54 | — | $0 | 6,107 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2018-03-15 | 2018-03-16 | 1,370 | $26.24 | $35.9K | 25,767 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2018-03-15 | 2018-03-16 | 442 | $81.22 | $35.9K | 25,325 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2018-03-15 | 2018-03-16 | 142 | $81.22 | $11.5K | 24,397 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2018-03-15 | 2018-03-16 | 835 | $13.90 | $11.6K | 24,539 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2018-03-15 | 2018-03-16 | 9 | $81.22 | $731 | 23,704 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2018-03-15 | 2018-03-16 | 54 | $13.71 | $740 | 23,713 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2018-03-15 | 2018-03-16 | 40 | $81.22 | $3.2K | 23,659 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2018-03-15 | 2018-03-16 | 241 | $13.71 | $3.3K | 23,699 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2018-03-05 | 2018-03-07 | 70,000 | — | $0 | 70,000 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2017-08-03 | 2017-08-07 | 9,752 | — | $0 | 0 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2017-08-03 | 2017-08-07 | 3,169 | $37.88 | $120.0K | 23,458 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2017-08-03 | 2017-08-07 | 9,752 | — | $0 | 26,627 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2017-07-20 | 2017-07-21 | 2,500 | $13.71 | $34.3K | 15,774 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2017-07-20 | 2017-07-21 | 3,418 | $41.00 | $140.1K | 16,875 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2017-07-20 | 2017-07-21 | 2,500 | $13.71 | $34.3K | 22,793 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2017-07-20 | 2017-07-21 | 2,500 | $41.00 | $102.5K | 20,293 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2017-05-19 | 2017-06-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2017-03-10 | 2017-03-14 | 4,924 | — | $0 | 4,924 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2017-03-10 | 2017-03-14 | 22,576 | — | $0 | 22,576 | SEC↗ |